The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens
Open accessPublished version of a preprint
Abstract
Functional genomics approaches can overcome limitations-such as the lack of identification of robust targets and poor clinical efficacy-that hamper cancer drug development. Here we performed genome-scale CRISPR-Cas9 screens in 324 human cancer cell lines from 30 cancer types and developed a data-driven framework to prioritize candidates for cancer therapeutics. We integrated cell fitness effects with genomic biomarkers and target tractability for drug development to systematically prioritize new targets in defined tissues and genotypes. We verified one of our most promising dependencies, the Werner syndrome ATP-dependent helicase, as a synthetic lethal target in tumours from multiple cancer types with microsatellite instability. Our analysis provides a resource of cancer dependencies, generates a framework to prioritize cancer drug targets and suggests specific new targets. The principles described in this study can inform the initial stages of drug development by contributing to a new, diverse and more effective portfolio of cancer drug targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the MSI that often leads to cancer simultaneously makes the inhibition of Werner syndrome ATP-dependent helicase (WRN) lethal to the tumor cells62,63”
From The origins and genetic interactions of KRAS mutations are allele- and tissue-specific (2021) · cites this paper as [62]
In the citing paper
“''Fitness Scores'' that were calculated from large-scale genome-wide CRISPR/Cas9 screens across 31 independent CRC cell lines and represent a quantitative measure of the reduction of cell viability elicited by a gene inactivation via CRISPR/Cas9 (https://score.depmap.sanger.ac.uk) (Behan et al., 2019;van der Meer et al., 2019).”
From Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer (2021) · cites this paper as Behan et al., 2019
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Differential expression analysis for sequence count data
Anders, S., & Huber, W. (2010) · Genome Biology · doi:10.1186/gb-2010-11-10-r106 · Cited by 15,581
Statistical significance for genomewide studies
Storey, J. D., & Tibshirani, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1530509100 · Cited by 9,692
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Le, D. T., Uram, J. N., Wang, H., Bartlett, B. R., Kemberling, H., Eyring, A. D., Skora, A. D., Luber, B. S., Azad, N. S., Laheru, D., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500596 · Cited by 9,377
voom: precision weights unlock linear model analysis tools for RNA-seq read counts
Law, C. W., Chen, Y., Shi, W., & Smyth, G. K. (2014) · Genome Biology · doi:10.1186/gb-2014-15-2-r29 · Cited by 6,155
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234
Zehir, A., Benayed, R., Shah, R. H., Syed, A., Middha, S., Kim, H. R., Srinivasan, P., Gao, J., Chakravarty, D., Devlin, S. M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4333 · Cited by 3,380 · cited 1×
“Most patients however do not benefit from such targeted therapies in part due to limited knowledge of candidate targets(Zehir et al. 2017).”
Defining a Cancer Dependency Map
Tsherniak, A., Vazquez, F., Montgomery, P. G., Weir, B. A., Kryukov, G., Cowley, G. S., Gill, S., Harrington, W. F., Pantel, S., Krill-Burger, J. M., et al. (2017) · Cell · doi:10.1016/j.cell.2017.06.010 · Cited by 3,276
Cited by
Sorted by citations
Items 201–300 of 999
DeWeirdt, P. C., McGee, A. V., Zheng, F., Nwolah, I., Hegde, M., & Doench, J. G. (2022) · Nature Communications · doi:10.1038/s41467-022-33024-2 · Cited by 50
MOB (Mps one Binder) Proteins in the Hippo Pathway and Cancer
Gündoğdu, R., & Hergovich, A. (2019) · Cells · doi:10.3390/cells8060569 · Cited by 50
Advances in Genomics for Drug Development
Spreafico, R., Soriaga, L. B., Grosse, J., Virgin, H. W., & Telenti, A. (2020) · Genes · doi:10.3390/genes11080942 · Cited by 56
Delgobo, M., Gonçalves, R. M., Delazeri, M. A., Falchetti, M., Zandoná, A., das Neves, R. N., Almeida, K., Fagundes, A. C., Gelain, D. P., Fracasso, J. I., et al. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.10.020 · Cited by 53
Computational methods, databases and tools for synthetic lethality prediction
Wang, J., Zhang, Q., Han, J., Zhao, Y., Zhao, C., Yan, B., Dai, C., Wu, L., Wen, Y., Zhang, Y., et al. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac106 · Cited by 52
Köferle, A., Schlattl, A., Hörmann, A., Thatikonda, V., Popa, A., Spreitzer, F., Ravichandran, M. C., Supper, V., Oberndorfer, S., Puchner, T., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110636 · Cited by 49
CRISPR screening and cell line IC50 data reveal novel key genes for trametinib resistance
Liu, H., & Wang, P. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01538-2 · Cited by 50
Lampson, B. L., Ramίrez, A. S., Baro, M., He, L., Hegde, M., Koduri, V., Pfaff, J. L., Hanna, R. E., Kowal, J., Shirole, N. H., et al. (2024) · Cell · doi:10.1016/j.cell.2024.03.022 · Cited by 49
Lord, C. J., Quinn, N., & Ryan, C. J. (2020) · eLife · doi:10.7554/elife.58925 · Cited by 46
A systematic genome-wide mapping of oncogenic mutation selection during CRISPR-Cas9 genome editing
Sinha, S., Barbosa, K., Cheng, K., Leiserson, M. D. M., Jain, P., Deshpande, A. J., Wilson, D. M., Ryan, B. M., Luo, J., Ronai, Z. A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26788-6 · Cited by 56
Unleashing Cell-Intrinsic Inflammation as a Strategy to Kill AML Blasts
Ellegast, J. M., Alexe, G., Hamze, A., Lin, S., Uckelmann, H. J., Rauch, P. J., Pimkin, M., Ross, L. S., Dharia, N. V., Robichaud, A. L., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0956 · Cited by 49
Feng, X., Tang, M., Dede, M., Su, D., Pei, G., Jiang, D., Wang, C., Chen, Z., Li, M., Nie, L., et al. (2022) · Science Advances · doi:10.1126/sciadv.abm6638 · Cited by 45
Structure of the MRAS–SHOC2–PP1C phosphatase complex
Hauseman, Z. J., Fodor, M., Dhembi, A., Viscomi, J., Egli, D., Bleu, M., Katz, S., Park, E., Jang, D. M., Porter, K. A., et al. (2022) · Nature · doi:10.1038/s41586-022-05086-1 · Cited by 48
Kyrochristos, I. D., & Roukos, D. H. (2019) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2019.101894 · Cited by 49
Eukaryotic clamp loaders and unloaders in the maintenance of genome stability
Lee, K., & Park, S. H. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00533-3 · Cited by 48
Chang, L., Jung, N. Y., Atari, A., Rodriguez, D. J., Kesar, D., Song, T., Rees, M. G., Ronan, M. M., Li, R., Ruiz, P. A., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01515-7 · Cited by 48
Short H2A histone variants are expressed in cancer
Chew, G.-L., Bleakley, M., Bradley, R. K., Malik, H. S., Henikoff, S., Molaro, A., & Sarthy, J. F. (2021) · Nature Communications · doi:10.1038/s41467-020-20707-x · Cited by 46
Metabolic impairment of non-small cell lung cancers by mitochondrial HSPD1 targeting
Parma, B., Ramesh, V., Gollavilli, P. N., Siddiqui, A., Pinna, L., Schwab, A., Marschall, S., Zhang, S., Pilarsky, C., Napoli, F., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02049-8 · Cited by 46
Targeting axonal guidance dependencies in glioblastoma with ROBO1 CAR T cells
Chokshi, C., Shaikh, M. V., Brakel, B. A., Rossotti, M. A., Tieu, D. D., Maich, W. T., Anand, A., Chafe, S. C., Zhai, K., Suk, Y., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03138-9 · Cited by 50
High-resolution functional mapping of RAD51C by saturation genome editing
Olvera-León, R., Zhang, F., Offord, V., Zhao, Y., Tan, H. K., Gupta, P., Pal, T., Robles-Espinoza, C. D., Arriaga-González, F. G., Matsuyama, L. S. A. S., et al. (2024) · Cell · doi:10.1016/j.cell.2024.08.039 · Cited by 44
Systematic functional identification of cancer multi-drug resistance genes
Lau, M.-T., Ghazanfar, S., Parkin, A., Chou, A. S. Y., Rouaen, J. R. C., Littleboy, J. B., Nessem, D., Khuong, T. M., Névoltris, D., Schofield, P., et al. (2020) · Genome biology · doi:10.1186/s13059-020-1940-8 · Cited by 45
Liu, C., Zhao, J., Lü, W., Dai, Y., Hockings, J. K., Zhou, Y., Nussinov, R., Eng, C., & Cheng, F. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007701 · Cited by 46
Ramakrishnan, R., Peña‐Martínez, P., Agarwal, P., Rodriguez‐Zabala, M., Chapellier, M., Högberg, C., Eriksson, M. D., Yudovich, D., Shah, M., Ehinger, M., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107684 · Cited by 46
CRISPR screening identifies CDK12 as a conservative vulnerability of prostate cancer
Lei, H., Wang, Z., Jiang, D., Liu, F., Liu, M., Lei, X., Yang, Y., He, B., Yan, M., Huang, H. W., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04027-6 · Cited by 47
Xu, G., Wang, H., Yuan, D., Yao, J., Li, M., Li, K., Zhang, Y., Dang, C., & Zhu, K. (2020) · Clinical & Translational Oncology · doi:10.1007/s12094-020-02335-5 · Cited by 45
A suspension technique for efficient large-scale cancer organoid culturing and perturbation screens
Price, S., Bhosle, S. G., Gonçalves, E., Li, X., McClurg, D. P., Barthorpe, S., Beck, A., Hall, C., Lightfoot, H. W., Farrow, L., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-09508-y · Cited by 47
Self-citationGenome-scale pan-cancer interrogation of lncRNA dependencies using CasRx
Montero, J. J., Trozzo, R., Sugden, M., Öllinger, R., Belka, A., Zhigalova, E., Waetzig, P., Engleitner, T., Schmidt‐Supprian, M., Saur, D., et al. (2024) · Nature Methods · doi:10.1038/s41592-024-02190-0 · Cited by 50
Bretherick, A. D., Canela-Xandri, O., Joshi, P. K., Clark, D. W., Rawlik, K., Boutin, T. S., Zeng, Y., Amador, C., Navarro, P., Rudan, I., et al. (2020) · PLOS Genetics · doi:10.1371/journal.pgen.1008785 · Cited by 42
Systematic illumination of druggable genes in cancer genomes
Jiang, J., Yuan, J., Hu, Z., Zhang, Y., Zhang, T., Xu, M., Long, M., Fan, Y., Tanyi, J. L., Montone, K. T., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110400 · Cited by 47
David, F., Davis, A. M., Gossing, M., Hayes, M. A., Romero, E., Scott, L. H., & Wigglesworth, M. J. (2021) · SLAS DISCOVERY · doi:10.1177/24725552211000669 · Cited by 45
Ravichandran, M., & Maddalo, D. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1273994 · Cited by 47
Guo, Y., Wang, J., Benedict, B., Yang, C. G., van Gemert, F. P. A., Ma, X., Gao, D., Wang, H., Zhang, S., Lieftink, C., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00981-0 · Cited by 45
Wang, J., Chen, C., Wang, L., Xie, M., Ge, X., Wu, S., He, Y., Mou, X., Ye, C., & Sun, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.872531 · Cited by 46
Chronos: a CRISPR cell population dynamics modelPreprint
Dempster, J. M., Boyle, I., Vázquez, F., Root, D. E., Boehm, J. S., Hahn, W. C., Tsherniak, A., & McFarland, J. M. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.25.432728 · Cited by 44
CRISPR Screens in Synthetic Lethality and Combinatorial Therapies for Cancer
Castells‐Roca, L., Tejero, E., Rodríguez‐Santiago, B., & Surrallés, J. (2021) · Cancers · doi:10.3390/cancers13071591 · Cited by 45
Wei, H., Li, A., Liu, Y., Xiao, X., Christiani, D. C., Hung, R. J., McKay, J., Field, J. K., Amos, C. I., & Cheng, C. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-1903 · Cited by 45
Hosseini, S., & Zhou, X. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac588 · Cited by 43
Large-scale Pan-cancer Cell Line Screening Identifies Actionable and Effective Drug Combinations
Bashi, A. C., Coker, E. A., Bulusu, K. C., Jaaks, P., Crafter, C., Lightfoot, H. W., Milo, M., McCarten, K., Jenkins, D. F., van der Meer, D. J., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-23-0388 · Cited by 43
Self-citationCELLector: Genomics-Guided Selection of Cancer In Vitro Models
Najgebauer, H., Yang, M., Francies, H. E., Pacini, C., Stronach, E. A., Garnett, M. J., Sáez-Rodríguez, J., & Iorio, F. (2020) · Cell Systems · doi:10.1016/j.cels.2020.04.007 · Cited by 43
Self-citationSynthetic augmentation of cancer cell line multi-omic datasets using unsupervised deep learning
Cai, Z., Apolinário, S., Baião, A. R., Pacini, C., Sousa, M. D., Vinga, S., Reddel, R. R., Robinson, P. J., Garnett, M. J., Zhong, Q., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54771-4 · Cited by 49
Self-citationMechanosensitive genomic enhancers potentiate the cellular response to matrix stiffness
Cosgrove, B. D., Bounds, L. R., Taylor, C. K., Su, A. L., Rizzo, A. J., Barrera, A., Sun, T., Safi, A., Song, L., Whitlow, T. J., et al. (2025) · Science · doi:10.1126/science.adl1988 · Cited by 43
Yan, F., Zhao, W., Xu, X., Li, C., Li, X., Liu, S., Shi, L., & Wu, Y. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.585251 · Cited by 42
Béal, J., Pantolini, L., Noël, V., Barillot, E., & Calzone, L. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007900 · Cited by 47
Siddiqui, A., Gollavilli, P. N., Ramesh, V., Parma, B., Schwab, A., Vazakidou, M. E., Natesan, R., Saatci, Ö., Rapa, I., Bironzo, P., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01095-x · Cited by 41
Mengoli, V., Ceppi, I., Sanchez, A., Cannavò, E., Halder, S., Scaglione, S., Gaillard, P.-H. L., McHugh, P. J., Riesen, N., Pettazzoni, P., et al. (2022) · The EMBO Journal · doi:10.15252/embj.2022111998 · Cited by 42
Palacios, A. M., Korus, P., Wilkens, B. G. C., Heshmatpour, N., & Patnaik, S. R. (2024) · Frontiers in Genome Editing · doi:10.3389/fgeed.2024.1342193 · Cited by 49
CRISPR screen in mechanism and target discovery for cancer immunotherapy
Liu, D., Zhao, X., Tang, A., Xu, X., Liu, S., Zha, L., Ma, W., Zheng, J., & Shi, M. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188378 · Cited by 44
DNA helicases and their roles in cancer
Dhar, S., Datta, A., & Brosh, R. M. (2020) · DNA repair · doi:10.1016/j.dnarep.2020.102994 · Cited by 42
Beyond Kinases: Targeting Replication Stress Proteins in Cancer Therapy
Baillie, K. E., & Stirling, P. C. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.10.010 · Cited by 42
Savino, A., Provero, P., & Poli, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249461 · Cited by 40
The deubiquitylase USP9X controls ribosomal stalling
Clancy, A., Heride, C., Pinto-Fernández, A., Elcocks, H., Kallinos, A., Kayser-Bricker, K. J., Wang, W., Smith, V., Davis, S. A., Fessler, S. P., et al. (2020) · The Journal of Cell Biology · doi:10.1083/jcb.202004211 · Cited by 40
Haggag, Y. A., Yasser, M., Tambuwala, M. M., Eltokhy, S. S., Isreb, M., & Donia, A. A. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120532 · Cited by 41
Selective Modulation of a Pan-Essential Protein as a Therapeutic Strategy in Cancer
Malone, C. F., Dharia, N. V., Kugener, G., Forman, A. B., Rothberg, M. V., Abdusamad, M., Gonzalez, A. E., Kuljanin, M., Robichaud, A. L., Conway, A. S., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1213 · Cited by 37
Integrative oncogene-dependency mapping identifies RIT1 vulnerabilities and synergies in lung cancer
Vichas, A., Riley, A. K., Nkinsi, N. T., Kamlapurkar, S., Parrish, P. C. R., Lo, A., Duke, F. F., Chen, J., Fung, I., Watson, J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24841-y · Cited by 43
Tumor-derived systems as novel biomedical tools—turning the enemy into an ally
Desai, N., Katare, P., Makwana, V., Salave, S., Vora, L. K., & Giri, J. (2023) · Biomaterials Research · doi:10.1186/s40824-023-00445-z · Cited by 45
Luo, C., Zhang, R., Guo, R., Wu, L., Xue, T., He, Y., Jin, Y., Zhao, Y., Zhang, Z., Zhang, P., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.02.007 · Cited by 37
The conditional nature of gene essentiality
Larrimore, K. E., & Rancati, G. I. (2019) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2019.07.015 · Cited by 39
The Bibliometric Landscape of Gene Editing Innovation and Regulation in the Worldwide
Wei, X., Pu, A., Liu, Q., Hou, Q., Zhang, Y., An, X., Long, Y., Jiang, Y., Dong, Z., Wu, S., et al. (2022) · Cells · doi:10.3390/cells11172682 · Cited by 39
Benchmarking machine learning methods for synthetic lethality prediction in cancer
Feng, Y., Long, Y., Wang, H., Ouyang, Y., Li, Q., Wu, M., & Zheng, J. (2024) · Nature Communications · doi:10.1038/s41467-024-52900-7 · Cited by 41
Salvati, A., Gigantino, V., Nassa, G., Giurato, G., Alexandrova, E., Rizzo, F. M., Tarallo, R., & Weisz, A. (2019) · Cancers · doi:10.3390/cancers11111720 · Cited by 38
Critical review on where CRISPR meets molecular diagnostics
Lau, A., Ren, C. L., & Lee, L. P. (2020) · Progress in Biomedical Engineering · doi:10.1088/2516-1091/abbf5e · Cited by 42
Genome-scale CRISPR screening at high sensitivity with an empirically designed sgRNA library
Henkel, L., Rauscher, B., Schmitt, B. A., Winter, J., & Boutros, M. (2020) · BMC Biology · doi:10.1186/s12915-020-00905-1 · Cited by 40
Review of applications of CRISPR-Cas9 gene-editing technology in cancer research
Zhao, Z., Li, C., Tong, F., Deng, J., Huang, G., & Sang, Y. (2021) · Biological Procedures Online · doi:10.1186/s12575-021-00151-x · Cited by 42
EVI1 drives leukemogenesis through aberrant ERG activation
Schmoellerl, J., Barbosa, I. A. M., Minnich, M., Andersch, F., Smeenk, L., Havermans, M., Eder, T., Neumann, T., Jude, J., Fellner, M., et al. (2022) · Blood · doi:10.1182/blood.2022016592 · Cited by 41
Das, R., Sjöström, M., Shrestha, R., Yogodzinski, C., Egusa, E. A., Chesner, L. N., Chen, W. S., Chou, J., Dang, D. K., Swinderman, J. T., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24919-7 · Cited by 38
Shi, B., Ding, J., Qi, J., & Gu, Z. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.51703 · Cited by 39
Gauthier-Coles, G., Bröer, A., McLeod, M. D., George, A. J., Hannan, R. D., & Bröer, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.963066 · Cited by 38
Parker, M. J., Lee, H., Yao, S., Irwin, S., Hwang, S., Belanger, K., de Maré, S. W., Surgenor, R. R., Lu, Y., Gee, P., et al. (2023) · Biochemistry · doi:10.1021/acs.biochem.2c00599 · Cited by 38
Building a translational cancer dependency map for The Cancer Genome Atlas
Shi, X., Gekas, C., Verduzco, D., Petiwala, S. M., Jeffries, C. T., Lu, C., Murphy, E., Anton, T., Vo, A. H., Xiao, Z., et al. (2024) · Nature Cancer · doi:10.1038/s43018-024-00789-y · Cited by 39
Discovering functional evolutionary dependencies in human cancers
Mina, M., Iyer, A., Tavernari, D., Raynaud, F., & Ciriello, G. (2020) · Nature Genetics · doi:10.1038/s41588-020-0703-5 · Cited by 37
Self-assembly of mesoscale collagen architectures and applications in 3D cell migration
Liu, C., Nguyen, R. Y., Pizzurro, G. A., Zhang, X., Gong, X., Rossello‐Martinez, A., & Mak, M. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.11.011 · Cited by 39
Sparse dictionary learning recovers pleiotropy from human cell fitness screens
Pan, J., Kwon, J. J., Talamas, J. A., Borah, A. A., Vazquez, F., Boehm, J. S., Tsherniak, A., Zitnik, M., McFarland, J. M., & Hahn, W. C. (2022) · Cell Systems · doi:10.1016/j.cels.2021.12.005 · Cited by 37
Uncovering cancer vulnerabilities by machine learning prediction of synthetic lethality
Benfatto, S., Serçin, Ö., Dejure, F. R., Abdollahi, A., Zenke, F. T., & Mardin, B. R. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01405-8 · Cited by 37
Mapping the binding sites of challenging drug targets
Wakefield, A., Kozakov, D., & Vajda, S. (2022) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2022.102396 · Cited by 37
McDonagh, E. M., Trynka, G., McCarthy, M. I., Holzinger, E. R., Shameer, K., Nakić, N., Hu, X., Cornu, H., Dunham, I., & Hulcoop, D. G. (2024) · Annual Review of Biomedical Data Science · doi:10.1146/annurev-biodatasci-102523-103838 · Cited by 36
Genome-wide pan-GPCR cell libraries accelerate drug discovery
Yang, H., Wang, Y., Liu, W., He, T., Liao, J., Qian, Z., Zhao, J., Cong, Z., Sun, D., Liu, Z., et al. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.06.023 · Cited by 37
Public Resources for Chemical Probes: The Journey so Far and the Road Ahead
Antolín, A. A., Workman, P., & Al‐Lazikani, B. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2019-0231 · Cited by 37
Specific Regulation of m6A by SRSF7 Promotes the Progression of Glioblastoma
Cun, Y., An, S., Zheng, H., Lan, J., Chen, W., Luo, W., Yao, C., Li, X., Huang, X., Sun, X., et al. (2021) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2021.11.001 · Cited by 36
Navarro-Carrasco, E., & Lazo, P. A. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.683038 · Cited by 34
Comparative optimization of combinatorial CRISPR screens
Li, R., Klingbeil, O., Monducci, D., Young, M. J., Rodriguez, D. J., Bayyat, Z., Dempster, J. M., Kesar, D., Yang, X., Zamanighomi, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30196-9 · Cited by 37
Loevenich, L. P., Tschurtschenthaler, M., Rokavec, M., Silva, M. G., Jesinghaus, M., Kirchner, T., Klauschen, F., Saur, D., Neumann, J. H. L., Hermeking, H., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-1247 · Cited by 38
The chemical biology of apoptosis: Revisited after 17 years
Yang, S., Mao, Y., Zhang, H., Xu, Y., An, J., & Huang, Z. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.05.019 · Cited by 35
Kim, J. Y., Kim, J.-K., & Kim, H. (2019) · Oncogene · doi:10.1038/s41388-019-1118-6 · Cited by 39
Newman, J. A., Gavard, A. E., Lieb, S., Ravichandran, M. C., Hauer, K., Werni, P., Geist, L., Böttcher, J., Engen, J. R., Rumpel, K., et al. (2020) · Life Science Alliance · doi:10.26508/lsa.202000795 · Cited by 37
Overview of Ferroptosis and Synthetic Lethality Strategies
Kinowaki, Y., Taguchi, T., Onishi, I., Kirimura, S., Kitagawa, M., & Yamamoto, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179271 · Cited by 36
Identifying novel therapeutic targets in gastric cancer using genome-wide CRISPR-Cas9 screening
Zeng, Z. R., Zhang, X., Jiang, C., Zhang, Y., Wu, X., Li, J., Tang, S., Li, L., Gu, L., Xie, X., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02177-1 · Cited by 35
Inferring compound heterozygosity from large-scale exome sequencing data
Guo, M. H., Francioli, L. C., Stenton, S. L., Goodrich, J. K., Watts, N. A., Singer‐Berk, M., Groopman, E., Darnowsky, P. W., Solomonson, M., Baxter, S. M., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01608-3 · Cited by 35
Optimizing cancer treatment: the synergistic potential of CAR-T cell therapy and CRISPR/Cas9
Amiri, M., Moaveni, A. K., Zolbin, M. M., Shademan, B., & Nourazarian, A. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1462697 · Cited by 37
Structure-based view of the druggable genome
Wang, J., Yazdani, S., Han, A., & Schapira, M. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.02.006 · Cited by 36
Giacosa, S., Pillet, C., Séraudie, I., Guyon, L., Wallez, Y., Roelants, C., Battail, C., Evrard, B., Chalmel, F., Barette, C., et al. (2021) · Cancers · doi:10.3390/cancers13030576 · Cited by 43
A Tale of Ice and Fire: The Dual Role for 17β-Estradiol in Balancing DNA Damage and Genome Integrity
Pescatori, S., Berardinelli, F., Albanesi, J., Ascenzi, P., Marino, M., Antoccia, A., di Masi, A., & Acconcia, F. (2021) · Cancers · doi:10.3390/cancers13071583 · Cited by 35
Natural variants suppress mutations in hundreds of essential genes
Parts, L., Batté, A., Lopes, M., Yuen, M. W.-K., Laver, M., Luis, B.-J. S., Yue, J., Pons, C., Eray, E., Aloy, P., et al. (2021) · Molecular Systems Biology · doi:10.15252/msb.202010138 · Cited by 34
Mlilo, S., & Sibanda, S. (2021) · South African Journal of Botany · doi:10.1016/j.sajb.2021.11.022 · Cited by 34
Xie, J., Wen, M., Zhang, J., Wang, Z., Wang, M., Qiu, Y., Zhao, W., Zhu, F., Yao, M., Rong, Z., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-2187 · Cited by 37
Krill-Burger, J. M., Dempster, J. M., Borah, A. A., Paolella, B. R., Root, D. E., Golub, T. R., Boehm, J. S., Hahn, W. C., McFarland, J. M., Vázquez, F., et al. (2023) · Genome biology · doi:10.1186/s13059-023-03020-w · Cited by 35
Yu, J., Feng, H., Sang, Q., Li, F., Chen, M., Yu, B., Xu, Z., Pan, T., Wu, X., Hou, J., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104451 · Cited by 33
Rahimi, A., Esmaeili, Y., Dana, N., Dabiri, A., Rahimmanesh, I., Jandaghian, S., Vaseghi, G., Shariati, L., Zarrabi, A., Javanmard, S. H., et al. (2023) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2023.106476 · Cited by 36
Peng, S., Long, M., Chen, Q.-S., Yin, Z., Zeng, C., Zhang, W., Wen, Q., Zhang, X., Ke, W., & Wu, Y. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02418-8 · Cited by 38
Advancements in CRISPR/Cas systems for disease treatment
Xu, Y., Le, H., Wu, Q., Wang, N., & Gong, C. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.05.007 · Cited by 35
The cell stress response: extreme times call for post‐transcriptional measures
Pizzinga, M., Harvey, R. F., Garland, G. D., Mordue, R., Dezi, V., Ramakrishna, M., Sfakianos, A., Monti, M., Mulroney, T. E., Pöyry, T. A. A., et al. (2019) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1578 · Cited by 32
Metadata
- Authors
- Behan, F. M., Iorio, F., Picco, G., Gonçalves, E., Beaver, C. M., Migliardi, G., Santos, R., Rao, Y., Sassi, F., Pinnelli, M., Ansari, R., Harper, S., Jackson, D. A., McRae, R., Pooley, R., Wilkinson, P., van der Meer, D., Dow, D., Buser-Doepner, C., Bertotti, A., Trusolino, L., Stronach, E. A., Saez-Rodriguez, J., Yusa, K., & Garnett, M. J.
- Affiliations
- Wellcome Sanger Institute (GB)
- European Bioinformatics Institute (GB)
- Candiolo Cancer Institute (IT)
- GlaxoSmithKline (United Kingdom) (GB)
- GlaxoSmithKline (United States) (US)
- Kyoto University (JP)
- Corresponding author
- Yusa, Kosuke
- Garnett, Mathew J.
- ORCID
- Venue
- Nature
- Published
- 2019-04-10
- Volume
- 568
- Issue
- 7753
- Pages
- 511-516
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2936686072
- Cited by
- 1,338
- References
- 64
- Citations by year
- 2026: 129 · 2025: 168 · 2024: 200 · 2023: 158 · 2022: 200 · 2021: 227 · 2020: 179 · 2019: 74
- FWCI
- 56.69
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- Locations
- Nature (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
- RePEc: Research Papers in Economics (submittedVersion)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- Funders
- Wellcome Trust (C44943/A22536, SU2C-AACR-DT1213, 102696, 206194)
- Cancer Research UK (A22536, SU2C-AACR-DT1213, 102696, C44943/A22536)
- Associazione Italiana per la Ricerca sul Cancro (5X 1000, 21091, 20697, 18532)
- Stand Up To Cancer (SU2C-AACRDT1213)
- H2020 European Research Council (724748)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- cancer cell lines, synthetic lethality, microsatellite instability, cancer dependency, genomic biomarkers, anticancer drug development
- MeSH terms
- Werner Syndrome Helicase, Synthetic Lethal Mutations, Gene Editing, Animals, Female, Humans, Neoplasm Transplantation, Neoplasms, Organ Specificity, Biomarkers, Tumor, Werner Syndrome, Reproducibility of Results, Genome, Human, Cell Line, Tumor, Mice, Microsatellite Instability, Drug Discovery, Molecular Targeted Therapy, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
